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Abstract 
Background: A highly regulated trafficking of cargo vesicles in eukaryotes performs protein delivery to a variety of 
cellular compartments of endomembrane system. The two main routes, the secretory and the endocytic pathways 
have pivotal functions in uni‑ and multi‑cellular organisms. Protein delivery and targeting includes cargo recognition, 
vesicle formation and fusion. Developing new tools to modulate protein trafficking allows better understanding the 
endomembrane system mechanisms and their regulation. The compound Sortin2 has been described as a protein 
trafficking modulator affecting targeting of the vacuolar protein carboxypeptidase Y (CPY), triggering its secretion in 
Saccharomyces cerevisiae.
Results: A reverse chemical‑genetics approach was used to identify key proteins for Sortin2 bioactivity. A genome‑
wide Sortin2 resistance screen revealed six yeast deletion mutants that do not secrete CPY when grown at Sortin2 
condition where the parental strain does: met18, sla1, clc1, dfg10, dpl1 and yjl175w. Integrating mutant phenotype and 
gene ontology annotation of the corresponding genes and their interactome pointed towards a high representation 
of genes involved in the endocytic process. In wild type yeast endocytosis towards the vacuole was faster in presence 
of Sortin2, which further validates the data of the genome‑wide screen. This effect of Sortin2 depends on structural 
features of the molecule, suggesting compound specificity. Sortin2 did not affect endocytic trafficking in Sortin2‑
resistant mutants, strongly suggesting that the Sortin2 effects on the secretory and endocytic pathways are linked.
Conclusions: Overall, the results reveal that Sortin2 enhances the endocytic transport pathway in Saccharomyces 
cerevisiae. This cellular effect is most likely at the level where secretory and endocytic pathways are merged. Them 
Sortin2 specificity over the endomembrane system places it as a powerful biological modulator for cell biology.
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Background
Eukaryotes have developed an intricate system of pro-
tein delivery to various cellular compartments, based on 
highly regulated trafficking of cargo vesicles. Cargo rec-
ognition, vesicle formation and fusion represent the core 
of endomembrane system processes and form two main 
routes, the secretory and the endocytic pathways. These 
two pathways have pivotal functions in uni- and multi-
cellular organisms. New discoveries have highlighted 
the role of the endomembrane system in diverse cellular 
processes such as cell polarity, signaling, development 
and response to environmental challenges [1, 2]. There-
fore, new and innovative tools to manipulate endomem-
brane trafficking are of great interest.
Chemical genomics is a powerful tool to discover such 
new biomodulators. It employs large diverse collections 
of compounds to identify small bioactive molecules in 
order to manipulate biological pathways in a similar fash-
ion to classical genetics [3, 4]. The bioactive compound 
may be used as an instrumental tool to manipulate bio-
logical processes even when the cognate target(s) is(are) 
still unknown. The identification of the members of drug-
sensitive pathways may aid in the identification and char-
acterization of novel intracellular networks. Successful 
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approaches for such duty have included biochemical and 
genetic analysis [5, 6].
Genetic approaches are usually carried out by genome-
wide screens that involve searching through collections 
of mutants for those with altered sensitivities to the drug, 
i.e., hypersensitivity or resistance. The most used model 
to carry out such screenings has been Saccharomyces cer-
evisiae deletion mutant collections, which have led to the 
identification of several novel components of cellular net-
works [7–9].
Drugs that impair vacuolar trafficking in S. cerevi-
siae have been identified and called sorting inhibitors 
(Sortins) [10]. These compounds mimic the phenotype of 
vacuolar protein sorting (vps) mutants [11–13] suggesting 
that they modify components of the endomembrane traf-
ficking pathway. A genome-wide hypersensitivity screen 
showed that Sortin2 affects primarily components within 
the endomembrane system in yeast [14]. This analysis 
identified 217 Sortin2 hypersensitive Saccharomyces 
deletion mutants in where the mutated genes are enrich-
ment on genes products involved on protein trafficking 
and localized particularly in endosomes [14]. Therefore 
the Sortin2 mode of action and the proteins involved on 
it are interesting subjects of study especially for further 
uses of the drug.
In order to identify proteins that are critical for the 
mode of action of Sortin2, we used a reverse chemical-
genetics approach; we performed a Sortin2-resistant 
genome-wide screening using a S. cerevisiae haploid dele-
tion library. We found six ORFs whose deletion caused 
Sortin2 resistance. Mutant phenotypes, GO annotation 
and the interactome of the corresponding genes indi-
cated endocytosis as the principal GO process. Con-
sistently, Sortin2 treatment enhanced trafficking of the 
endocytic tracer FM4-64 toward the vacuole. Analysis of 
structure–bioactivity relationships suggested that Sor-
tin2 effects on endocytosis toward the vacuole depend on 
Sortin2 structural features. Genetic and chemical analog 
analysis strongly suggests that the effect of Sortin2 on the 
secretory pathway is linked to its effect on endocytosis.
Results
Sortin2 resistance genome‑wide screen
In order to find important molecular component(s) for 
Sortin2 bioactivity in yeast, a screen for mutants resistant 
to Sortin2 was performed using a loss-of-function mutant 
collection of 4,800 haploid deletion S. cerevisiae strains. 
It was anticipated that this resistance screening would 
identify proteins required for Sortin2 bioactivity that 
were not codified by an essential gene. The parental strain 
secretes CPY when grown with 10 μM Sortin2 [14]. The 
primary screen was performed with Sortin2 47 μM that 
is almost five times higher of the minimal concentration 
that trigger CPY secretion in the wild type strain. There-
fore the screening could identify the strong resistance to 
Sortin2. Out of the entire collection, 36 putative resistant 
strains were identified (Additional file 1: Table S1). These 
strains were retested with different concentrations of 
Sortin2 to confirm the resistant phenotype. The thresh-
old to consider a strain resistant to Sortin2 was 10 μM 
because that was the concentration that trigger secretion 
of CPY in the wild type strain using peroxidase detec-
tion. Mutant strains that did not secrete CPY with 10 μM 
Sortin2 were considered as Sortin2-resistant mutants. 
Out of the 36 primary screen hits, 6 mutants were con-
firmed as resistant to Sortin2 by this dosage dependence 
analysis (Figure 1; Additional file 1: Table S1). The results 
showed that sla1, met18 and clc1 were resistant to up to 
40 µM Sortin2. Furthermore dfg10 and dpl1 were resist-
ant to Sortin2 up to 20 µM as well as the dubious mutant 
yjl175w. Sortin2 did not inhibit growth performance of 
the Sortin2-resistant mutants, which was evaluated by 
growing them in 47 µM of Sortin2 for 10 h (Additional 
file 2: Figure S1). Sortin2 does not inhibit the growth nei-
ther the viability of five of the Sortin2-resistant mutants 
when they grown for 72  h with 20  µM of the chemical 
(Additional file  3: Figure  S2). Therefore, the observed 
resistance to Sortin2 of met18, sla1, clc1, dfg10 and dpl1 
was not due to cell growth impairment but rather to 
changes in trafficking machinery that resulted in reduced 
secretion of CPY. In the case of yjl175w, which deletion 
affects a dubious gene, this condition of treatment inhib-
its its growth (Additional file  3: Figure  S2). Therefore 
the lack of CPY secretion resistance to Sortin2 could be 
due to a lower amount of cells and CPY detection limits. 
Interestingly Sortin2 increases the viability of met18 and 
dpl1 suggesting than this compound improve cell perfor-
mance (Additional file 3: Figure S2).
CPY is a vacuolar soluble protein that is secreted to the 
extracellular medium under certain chemical or genetic 
conditions [10, 15, 16]. Therefore, the Sortin2 resist-
ance observed in sla1, met18 and clc1 could be due to 
general defects in the secretory pathway in the mutant 
background. To test this hypothesis, Sortin1, which also 
induces secretion of CPY [10], was evaluated for its effect 
on CPY trafficking in identified resistant mutants. Sor-
tin1 was able to trigger CPY secretion in the sla1, met18 
and clc1 strains (Figure  1), suggesting that the mutants 
have a functional secretion pathway. Although Sortin1 
triggers CPY secretion in sla1 in much less extension 
than the parental strain the sensitivity of sla1 to three 
different CPY-secretion triggering compounds confirms 
its ability to secrete CPY (Additional file  4: Figure  S3). 
Importantly, Sortin1 treatment induced CPY-mistar-
geting in Sortin2-resistant mutants, indicating that the 
corresponding deletion confers resistance to certain 
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structural determinants of Sortin2. Furthermore, sla1, 
met18, clc1 and dfg10 were also resistant to the Sortin2 
structural analog 5537685, revealing that Sortin2 resist-
ance is specific for Sortin2-related structures in these 
strains (Figure 1). On the contrary, dpl1 and yjl175w were 
sensitive to 5537685 although their secretion was much 
weaker than the parental line. Therefore the Sortin2 
resistance of these two mutants could be due to struc-
tural differences between Sortin2 and 5537685 (Figure 1).
We further analyzed the gene ontology term represen-
tation for genes whose deletion provokes resistance to 
Sortin2. According to the GO annotation available in the 
S. cerevisiae database (SDG, http://www.yeastgenome.
org/), four of those genes encode proteins that are related 
to endomembrane trafficking: CLC1, SLA1, DFG10 and 
DPL1 (Table  1). This finding is consistent with the spe-
cific mode of action of Sortin2 on the yeast endomem-
brane system [14]. The CLC1 and SLA1 genes encode a 
clathrin light chain and an actin binding protein, respec-
tively, and are directly involved in endocytosis [17, 24]. In 
addition, sla1, met18, dfg10 and yjl175w mutants show 
endocytosis defects, indicating that the encoding proteins 
are important for this cellular process [39]. The YJL175W 
gene corresponds to a dubious ORF but its deletion also 
affects endocytosis [39]. Therefore among the genes that 
encode proteins required for Sortin2 bioactivity, five out 
of six genes participate in the endocytosis process.
Sortin2 enhances endocytic trafficking toward the vacuole 
in S. cerevisiae
Due to the functional characteristics of gene products 
affected in Sortin2-resistant mutants, the effect of Sor-
tin2 in the endocytic route was analyzed. Internaliza-
tion of the endocytic tracer FM4-64 [40] was analyzed 
by confocal microscopy (Figure  2a). In wild type S. 
cerevisiae (control), the FM4-64 dye reached the vacu-
ole in approximately 40  min (Figure  2b, c). However, 
in cells treated with Sortin2, FM4-64 reached the vac-
uole in 25  min (Figure  2b, c), while in wild type cells 
the FM4-64 was still localized to endosome structures 
(Figure  2b). This result indicates that Sortin2 likely 
enhances endocytic trafficking towards the vacuole in S. 
cerevisiae.
To determine the specificity of the Sortin2 impact on 
endocytosis, the effect of compounds structurally related 
to Sortin2 was analyzed. The results showed that chemi-
cals 5529640 and 5537685 speed up the FM4-64 endo-
cytic pathway similarly to Sortin2 (Figure  3, Additional 
file 5: Figure S4). Therefore changing the sulfonate group 
in Sortin2 did not have an impact in its effect on endo-
cytosis. Importantly, both 5670647 and 6269701 com-
pounds had no effect on endocytosis timing, indicating 
that functional groups on both ends of Sortin2 molecule 
are important for Sortin2 bioactivity (Figure 3, Additional 
file  5: Figure  S4). This result is consistent with the lack 
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Figure 1 Sortin2 S. cerevisiae resistance is specific to Sortin2‑related structures. Mutant and parental (WT) strains were grown in YPD medium sup‑
plemented with the indicated concentrations of Sortin2 (μM), compound 5537685 and Sortin1. The control condition (0 μM Sortin2) contained 1% 
DMSO, which is present in all conditions since it is the solvent for the three compounds. The presence of CPY was analyzed on the growth medium 
by dot‑blot using a CPY monoclonal antibody. The experiment was performed three times.
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of activity of 5670647 and very low potency of 6269701 
regarding CPY secretion [14].
Sortin2 does not alter endocytic trafficking in Sortin2 
resistant mutants
It has been demonstrated that Sortin2 not only impairs 
trafficking of CPY to the vacuole [10, 14] but also modi-
fies the kinetics of endocytic trafficking in Saccharomy-
ces cerevisiae. In order to test if the two phenotypes are 
linked, we analyzed whether Sortin2-resistant mutants 
were also resistant to the Sortin2 effect in endocytic traf-
ficking toward the vacuole. Due to the size of the met18 
mutant cells and subsequent difficulties in assessing their 
subcellular phenotypes, the met18 strain was not tested. 
Other Sortin2 resistant mutants were treated with Sor-
tin2 at a concentration that made FM4-64 trafficking 
to the vacuole faster in the parental line (Figure  4). At 
25 min FM4-64 labeled solely endosomes in all mutants 
treated with Sortin2, as in control conditions (Figure 4), 
indicating that mutations that confer Sortin2 resistance 
also suppressed the enhanced endocytosis phenotype 
observed for the wild-type strain. FM4-64 did not reach 
the vacuole at 25  min in any of the Sortin2-treated 
mutants. However, after 40 min of internalization FM4-
64 was localized in the vacuole membrane, indicating 
that the lack of Sortin2 effect was not due to mutant 
impairment of endocytosis (Additional file 6: Figure S5).
Interactome of proteins required for Sortin2 bioactivity
In order to determine whether identified gene products 
required for Sortin2 bioactivity are directly or indirectly 
involved in endocytic pathways, their interactome net-
work was determined using OSPREY software [41]. We 
used the six gene products as query to build the interac-
tome of physical and genetic interactions. The resulting 
network contained 273 nodes with edges representing 
physical or genetic interactions (data not shown). These 
nodes were classified according to their location and 
cell function using CellLoc and FunCat tools (http://
www.mips.gsf.de), respectively. The Sortin2 resistance 
Table 1 Gene ontology (GO) of genes whose deletion provokes resistance to Sortin2 in S. cerevisiae
Biological process, molecular function and cellular component GO are shown for each ORF.
Gene/ORF GO function GO process GO component References
SLA1
YBL007C
Protein binding, bridging1
Ubiquitin binding2
Actin binding3
Cytoskeletal protein binding4
Identical protein binding4
Actin cortical patch assembly5
Endocytosis6
Fungal‑type cell wall organiza‑
tion5
Actin cortical patch7
Cell cortex1
Nucleus8
Mating projection tip9
Cytoskeleton3
Endosome membrane3
Plasma membrane3
1Warren et al. [17]
2Stamenova et al. [18]
3UniProt‑GOA [19]
4DDB et al. [20]
5Pruyne and Bretscher [21]
6Howard et al. [22]
7Ayscough et al. [23]
8Gardiner et al. [24]
9Narayanaswamy et al. [25]
CLC1
YGR167W
Structural molecule activity1
Calmodulin binding2
Structural molecule activity3
Endocytosis4
Vesicle‑mediated Transport1,3
Intracellular protein transport3
Clathrin vesicle coat1
Clathrin coat of coated pit3
Clathrin coat of trans‑Golgi 
network vesicle3
1Pishvaee et al. [26]
2UniProt‑GOA [19]
3DDB et al. [20]
4Newpher and Lemmon [27]
MET18
YIL128W
Binding5 Methionine metabolic process1
Nucleotide‑excision repair2
Transcription from RNA poly‑
merase II promoter3
DNA repair6
Response to DNA damage 
stimulus6
Transcription, DNA‑dependent6
Cytoplasm4
Nucleus6
1Masselot and De Robichon‑
Szulmajster [28]
2Kou et al. [29]
3Lauder et al. [30]
4Huh et al. [31]
5DDB et al. [20]
6UniProt‑GOA [19]
DFG10
YIL049W
3‑Oxo‑5‑alpha‑steroid 4‑dehy‑
drogenase activity1
Oxidoreductase activity, act‑
ing on the CH–CH group of 
donors5
Dolichol biosynthetic process1
Pseudohyphal growth2
Lipid metabolic process5
Integral to membrane3,4,5
Endoplasmic reticulum mem‑
brane4
1Cantagrel et al. [32]
2Mosch and Fink [33]
3De Hertogh et al. [34]
4UniProt‑GOA [19]
5DDB et al. [20]
DPL1
YDR294C
Sphinganine‑1‑phosphate aldo‑
lase activity1
Carboxy‑lyase activity6
Pyridoxal phosphate binding6
Calcium‑mediated signaling2
Cellular response to starvation3
Sphingolipid metabolic process1
Carboxylic acid metabolic 
process6
Endoplasmic reticulum4,5 1Saba et al. [35]
2Birchwood et al. [36]
3Gottlieb et al. [37]
4Mukhopadhyay et al. [38]
5Huh et al. [31]
6DDB et al. [20]
YJL175W
YJL175W
Unknown Unknown Integral to membrane1 1De Hertogh et al. [34]
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interactome analysis showed genes involved in differ-
ent cellular process. The largest enrichment processes 
were “Cell fate” and “Cell type differentiation” followed 
by “Cell cycle and DNA processing” and “Cellular com-
munication/signal transduction mechanism” with 3.5, 
3.3, 2.4 and 2.4 fold enrichment on the Sortin2-resist-
ance interactome, respectively (Table 2). However, when 
more specific granular terms were analyzed, the results 
showed that the processes of “Regulation of DNA pro-
cessing” and “Endocytosis” had the highest enrichment, 
Figure 2 Sortin2 enhances internalization of FM4‑64. a Diagram of FM4‑64 endocytosis labeling. Cells were incubated with 24 μM FM4‑64 for 
30 min at 4°C for plasma membrane FM4‑64 binding. Then turned to 28°C (time 0) to be imaged subsequently at different times of incubation by 
confocal microscopy. Progressively FM4‑64 is progressively trafficking to intracellular compartments by endocytosis. b S. cerevisiae parental line was 
grown on YPD 1% DMSO (control) and YPD supplemented with 20 μM Sortin2. Two representative images of approximately 25 cells are shown in 
each condition. The experiment was performed three times. Scale bar represents 5 μm. c Cells with FM4‑64 labeled vacuoles were scored in each 
condition on b. The percentage of cells with FM4‑64 labeled vacuoles is informed with standard deviation.
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with values of 11.1- and 8.3-fold, respectively (Addi-
tional file  7: Table  S2). Moreover, the “Transcription 
elongation”, “Actin cytoskeleton” and “G2/M transition 
of mitotic cell cycle” processes were also highly enriched 
(more than 5-fold, Additional file  7: Table  S2). Regard-
ing the cell location of the Sortin2 resistance interac-
tome members, CellLoc categorization showed that the 
highest over-represented categories were “Cytoskeleton”, 
“Transport vesicles” and “Punctate composite” (3.9-, 2.5- 
and 2.7-fold, respectively; Table  2). The enrichment of 
the “Cytoskeleton” category corresponded mainly to the 
“Actin cytoskeleton” category, which was enriched nine-
fold in the Sortin2-resistance interactome (Table 2).
Discussion
Using a reverse chemical genetics approach six S. cer-
evisiae mutants were identified that did not show a CPY 
sorting defect when treated with Sortin2. This reverse 
chemical screen confirmed the specificity of the effect of 
Sortin2 within the endomembrane system as suggested 
previously for genes identified in Sortin2 hypersensitive 
screen [14]. The most enriched biological process among 
Sortin2-resistant mutants was endocytosis, and impor-
tantly, this compound affects the speed of internalization 
of an endocytic tracer towards the vacuole. These results 
show the power and consistency of genetic screens to 
unravel the effects of a bioactive compound and its 
specificity.
Sortin2-resistant mutants treated with Sortin2 did not 
show either CPY mistargeting or enhancing of the endo-
cytic pathway that was observed in the wild type. This 
genetic evidence suggests that the Sortin2 effects of traf-
ficking to the vacuole through the secretory system and 
endocytosis are linked. The Sortin2 structure–activity 
relationship analysis consistently supports this connec-
tion, since the Sortin2 effect on endocytosis depends on 
the same chemical features (see below) that have been 
shown for CPY trafficking [14]. As the endocytic path-
way converges on the same organelle, it is foreseeable 
that both observed phenotypes might be due to higher 
trafficking rate towards to vacuole at late endosome 
level. Sortin2-CPY secretion could be explained by lower 
abundance of CPY receptor at the TGN due to its higher 
anterograde trafficking rate. This is consistent with the 
Figure 3 Enhancing of endocytic trafficking depends on Sortin2 structural features. S. cerevisiae parental line was grown on YPD 1% DMSO (con‑
trol) and YPD supplemented with 20 μM of different Sortin2‑structural analogs. Afterwards cells were incubated with 24 μM FM4‑64 for 30 min at 
4°C. Then turned to 28°C to be imaged subsequently by confocal microscopy at different incubation times. Cells with FM4‑64 labeled vacuoles were 
scored. The number of cells with labeled vacuoles relative to the total scored population (N = 30 cells) in different times of FM4‑64 incubation is 
informed with standard deviation.
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faster traffic of FM4-64 endocytosis towards to vacu-
ole due to Sortin2. We were unable to define precisely 
whether the alteration of both pathways shares the same 
molecular mode of action. Data from Sortin2-hypersen-
sitive screen [14] together with the link between endocy-
tosis and secretory pathway support that Sortin2 cellular 
target is located at late endosomal trafficking events.
Since clc1, sla1 and met18 resistance is observed at 
any tested chemical concentration the mode of action 
of Sortin2 could involve its binding to the missing gene 
product in the corresponding mutant. However the pos-
sibility that these proteins are involved in Sortin2 intra-
cellular availability could not be rule out. In the case that 
the gene products interact with the bioactive molecule 
they may do so with the two part of Sortin2 since their 
loss of function mutants were resistant to 5537685 as 
well. In this scenario how Sortin2 affects both endocytic 
and secretory pathways is undetermined. Clc1 is a struc-
tural protein that allows generation of clathrin-coated 
vesicles (CCVs) from plasma membrane (PM) and TGN 
for endocytic and secretory pathways respectively [42]. 
Also Sla1 has a function in endocytic CCVs formation 
as is present at clathrin-coated pits at plasma membrane 
[43]. Interestingly it has been proposed a role of SLA1 
in late endosome-to-vacuole trafficking likely related 
to clathrin function as well [44, 45]. Based on the close 
functional relationship between Clc1 and Sla1 it is plausi-
ble that Sortin2 is interacting with the entire structure at 
the clathrin pit enhancing vesicle trafficking. In addition 
Met18 genetically interacts with Sla1 suggesting a related 
function however still unknown [46].
On the other hand, it is unlikely that YJL175W, DFG10 
and DPL1 gene products would correspond to the molec-
ular targets of Sortin2 since its deletions mutants are sen-
sitive to Sortin2 (20 μM and higher) on its effect on CPY 
trafficking. Likely in this case the lack of gene products 
induces a perturbation of endomembrane system which 
compensates the effect of Sortin2. Dfg10 participates in 
dolichol biosynthesis and its loss of function mutant has 
defects on CPY N-glycosylation [32] that could affect 
Figure 4 Sortin2 does not alter endocytic trafficking in Sortin2 resistant mutants. S. cerevisiae parental line (WT) and Sortin2 resistant mutants were 
grown on YPD supplemented with 1% DMSO (control) or 20 μM Sortin2. Cells were incubated with 24 μM FM4‑64 for 30 min at 4°C. Then turned 
to 28°C to be imaged after 25 min by confocal microscopy. Images of 25 min incubation are shown. Two images are representative of 20 cells. The 
experiment was done more than three times. Scale bar represents 5 μm.
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its secretion. Thus, Dfg10 deficiency could cause slower 
rate of CPY secretion therefore higher dose of Sortin2 
is required to trigger the same effect. Furthermore the 
partial resistance of dpl1 could be explained by com-
pensation effect on protein trafficking. dpl1 accumulates 
phytosphingosine-1-phosphate (PHS1P) which is the 
substrate Dpl1 metabolizes [35]. PHS1P has a signaling 
role in the cell affecting gene transcriptional level, which 
includes genes involved in protein sorting and targeting 
cellular process [47]. Therefore, the lack of Dpl1 could 
alter transcription levels of protein trafficking genes com-
pensating Sortin2 effect over trafficking pathways medi-
ates by PHS1P accumulation.
The physical and genetic interactome analysis revealed 
that one of the most enriched GO processes was “vesicu-
lar cellular import” (8.3-fold enrichment) in which all 
genes belong to the term “endocytosis”. This result sup-
ports our observations of FM4-64 internalization and 
confirms that most likely the still undetermined molecu-
lar targets of Sortin2 are related to the cellular trafficking 
pathways. Moreover, interactome GO component classi-
fication revealed that of all possible cellular components, 
only five locations had significant representation on the 
Sortin2-resistance dataset. Three of these are involved 
in or related to endomembrane system components; 
cytoskeleton, punctate composite and transport vesicles. 
The high representation of “DNA processing and tran-
scription elongation GO function” is consistent with the 
presence of MET18 within genes whose deletion confers 
resistance to Sortin2. In addition, high representation 
of these cellular functions correlates with the GO com-
ponent, showing that nuclear location is represented in 
the dataset. However how these types of GO molecular 
processes and MET18 function are related to protein 
trafficking still remains unclear. Interestingly, several pro-
teins involved in the endocytic process have been also 
related to chromatin remodeling, transcription and cell 
division functions supporting that those processes are 
somehow related [48, 49]. These findings may provide 
an explanation for highly represented processes in our 
interactome analysis and support that Sortin2 is affecting 
mainly endocytosis and/or endocytic-related processes.
Analyzing the structure–bioactivity relationship of Sor-
tin2 provided insight into the molecular mechanism of its 
mode of action. The Sortin2 analog that lacks the sulfonate 
group on Sortin2 causes no effect in the endocytosis time 
Table 2 Functional and locational gene product categorization of the interactome network of genes whose deletion pro-
vokes resistance to Sortin2 in S. cerevisiae
Category representation of the abundance within the Sortin2‑resistance interactome network (dataset 273 genes) and the S. cerevisiae genome (6131 genes). The 
p‑value was calculated using the hypergeometric distribution as the statistical test. p < 0.005 was considered as significant.
Representation on dataset
Sortin2  
interactome (%)
Genome (%) p‑value Enrichment 
in dataset (fold)
Functional category
Cell fate 15.5 4.5 1.77E−13 3.5
Cell type differentiation 24.2 7.4 1.90E−19 3.3
Cell cycle and DNA processing 39.1 16.5 2.32E−20 2.4
Cellular communication/signal transduction mechanism 9.1 3.8 4.38E−05 2.4
Biogenesis of cellular components 31.1 14.0 6.35E−14 2.2
Cell rescue, defense and virulence 19.2 9.0 6.05E−08 2.1
Protein fate (folding, modification, destination) 38.0 18.8 1.55E−14 2.0
Interaction with the environment 15.2 7.6 7.12E−06 2.0
Protein with binding function or cofactor requirement  
(structural or catalytic)
27.5 17.1 6.42E−06 1.6
Cellular transport, transport facilities and transport routes 25.3 16.9 1.82E−04 1.5
Transcription 23.5 17.5 5.99E−03 1.3
Locational category
Cytoskeleton 13.0 3.3 6.31E−13 3.9
 Actin cytoskeleton 8.0 0.9 3.55E−16 9.0
Punctate composite 6.2 2.3 1.63E−04 2.7
Transport vesicles 5.8 2.3 5.50E−04 2.5
Cytoplasm 61.2 46.3 2.91E−07 1.3
Nucleus 46.3 34.8 3.46E−05 1.3
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frame. Replacing the sulfonate group with a group with 
a dense electron cloud such the benzoic ring or carboxyl 
group restituted Sortin2 effect on endocytosis. However, 
compound 6269701 did not affect the endocytosis, show-
ing the importance of the chloride in the chlorobenzene 
ring. It is possible that rather than chloride itself being 
important, the lack of bioactivity is due to steric hindrance 
of the nitro group. Therefore, the effect of Sortin2 on 
endocytosis depends on these two parts of the molecule, 
the sulfonate group and the chlorobenzene ring.
Interestingly, for both biological effects of Sortin2 on 
endomembrane trafficking, the same structural features 
of Sortin2 are required. For triggering the secretion of 
CPY, it was shown that both structural features of Sor-
tin2, the sulfonate and the chlorobenzene ring are equally 
necessary [14]. Consistently, chemical 6269701 was also 
inactive for CPY trafficking [14]. Overall, the analysis of 
Sortin2 functional structure features strongly support a 
link between its effect on trafficking to the vacuole and 
the endocytic pathway.
Regarding Sortin2 as a tool for research, we would like 
to stress that this novel compound has a distinct biologi-
cal value since it activates specifically the endocytic traf-
ficking towards the vacuole while many discovered drugs 
block or inhibit cellular processes within endomembrane 
system. This compound is also very specific, affecting 
a restrictive set of cellular components. The power of 
using such a biological modulator has been proved by the 
extensive use of bioactive compounds in cell biology.
Conclusions
Critical S. cerevisiae proteins for the mode of action of 
Sortin2 have been identified by means of reverse chem-
ical-genetics approach. Endocytosis is the principal 
biological process targeted by Sortin2 base on mutant 
phenotypes, GO annotation and the interactome of the 
six ORFs whose deletion caused Sortin2 resistance. In 
fact Sortin2 treatment enhanced trafficking of the endo-
cytic tracer FM4-64 toward the vacuole supporting the 
consistence of the genetic data. Overall the link of the 
Sortin2 effect of on the secretory pathway and its effect 
on endocytosis is supported by the genetic, cellular and 
chemical data in S. cerevisiae.
Methods
Chemical treatments
Sortin2 and its related structures were obtained from 
ChemBridge (San Diego, CA, USA); the latter are 
referred to here by the identification numbers assigned 
by the manufacturer. S. cerevisiae were grown in regu-
lar Yeast Peptone Dextrose (YPD) liquid or solid (1.5% 
agar). Single yeast colonies were picked from YPD-agar 
plates, inoculated in liquid YPD and grown for 48  h at 
28°C with constant shaking to generate an initial culture 
for the assays. Chemical treatments were performed in 
medium supplemented with the designated compounds 
or 1% DMSO as a negative control. Cultures were grown 
with the chemical compound for 72 h at 28°C. To evalu-
ate the effect of Sortin2 on yeast growth performance, 
Sortin2-resistant strain cultures at equal initial optical 
density (OD600 = 0.2) were grown in YPD supplemented 
with 20 µM Sortin2 or 1% DMSO at 28°C. Subsequently 
OD600 was measured at different times. For evaluating 
cell viability, a fraction of cells grown in these conditions 
for 72 h were diluted 1 to 100,000 and plated on YPD on 
triplicates. Colony-forming unit (CFU) were scored after 
2 days. The assay was repeated twice.
Sortin2 resistance screening
The primary screen was performed using the S. cerevisiae 
haploid deletion library that contains 4,800 yeast strains 
generated from the BY4742 parental strain (MATal-
pha his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0; Open Biosystems, 
Huntsville, AL, USA). The strains (OD600  =  0.2) were 
grown in darkness in YPD liquid medium supplemented 
with 47 µM Sortin2 and 1% DMSO, in a microplate for-
mat. After 72 h, growth medium was collected and ana-
lyzed for secreted CPY as described previously [10] using 
alkaline phosphatase labeled secondary antibody. All 
the deletion strains that did not secrete CPY due to Sor-
tin2 in the primary screen were analyzed for CPY secre-
tion at increasing concentrations of Sortin2 (5, 10, 20 
and 40 μM). This assay was performed using peroxidase 
labeled secondary antibody to enhance its sensitivity and 
it was repeated three times. Mutants were considered as 
resistant to Sortin2 if CPY secretion was not detected at 
concentrations less than or equal to 10 μM because this 
was the concentration that trigger secretion of CPY in 
the wild type strain using peroxidase detection.
FM4‑64 endocytosis assay
Yeast cultures (OD600 = 0.2) were grown with 20 µM of 
chemical compound and 1% DMSO for 72  h at 28°C in 
darkness with constant shaking. Cell cultures were cen-
trifuged at 5,000 rpm for 4 min and re-suspended in fresh 
growth medium. Cells were incubated with 24 μM FM4-
64 (Invitrogen) at 4°C for 30 min. Subsequently, the FM4-
64-containing medium was replaced with fresh YPD 
medium and cultures was incubated at 28°C. To observe 
FM4-64 distribution, 5 µl of the suspension were placed 
on a slide pretreated with 1  mg/ml Convanavalin A. 
Endocytosis of FM4-64 was examined at 0, 15, 25, 40 and 
60 min at 28°C using Zeiss LSM 510 confocal microscope 
with a 543  nm emission filter. Approximately 25 cells 
were observed for each condition. The experiment was 
repeated three times; representative images are shown.
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Bioinformatic analysis
To retrieve information about gene annotation, gene prod-
ucts, gene ontology (GO) and mutant phenotypes of each 
ORF, the Saccharomyces Genome Database (SGD, http://
www.yeastgenome.org/) was queried. The interactome 
network was obtained by submitting the query gene prod-
ucts to the OSPREY 1.2.0 software platform [41]. Function 
and localization of gene products of the interactome net-
work were categorized using the FunCat and CellLoc clas-
sification systems from The Munich Information Center 
for Protein Sequences (MIPS, http://www.mips.gsf.de).
Additional files
Additional file 1: Table S1. Saccharomyces deletion strains selected 
on the Sortin 2 primary screen. All the 36 deletion mutants selected as 
Sortin2 resistant in the primary screen are listed. They were tested on a 
secondary screen for Sortin2 resistance classifying them as according wild 
type behavior (Wt) and resistant to Sortin2 (R). Results on the secondary 
screen were judged based on the behavior of experimental repetitions 
(Number of repetitions).
Additional file 2: Figure S1. Sortin2 short time treatment does not 
inhibit growth of Sortin2 resistant mutants. S. cerevisiae parental line (WT) 
and Sortin2 resistant mutants were grown on YPD supplemented with 
1% DMSO (control) and YPD supplemented with 47 μM Sortin2 (Sortin2). 
Growth performance was evaluated by OD600 at different incubation 
times. The assay was repeated twice with experimental triplicates.
Additional file 3: Figure S2. Sortin2 does not affect viability of Sortin2 
resistant mutants. S. cerevisiae parental line (WT) and Sortin2 resistant 
mutants were grown on YPD supplemented with 1% DMSO (control) 
and YPD supplemented with 20 μM Sortin2 (Sortin2) for 72 h. Number of 
cells were evaluated by measuring OD600 (A). A fraction of cells in every 
condition were plated in YPD medium to analyze viability. The results were 
expressed as colony‑forming unit (CFU) for every 108 cells (B) as well as 
a percentage of viability (C). Statistical significance was evaluated with 
Student´s t test (*p < 0.05, **p < 0.01).
Additional file 4: Figure S3. sla1 is sensitive to three different CPY‑
secretion triggering compounds. Parental (WT) and sla1 strains were 
grown in YPD medium supplemented with the indicated concentrations 
of Sortin2, furan, Brefeldin A and Endosidin1. The control condition (0 μM 
Sortin2) contained 1% DMSO. The presence of CPY was analyzed on the 
growth medium by dot‑blot using a CPY monoclonal antibody.
Additional file 5: Figure S4. Figure 3. Enhancing of endocytic traffick‑
ing depends on Sortin2 structural features. S. cerevisiae parental line was 
grown on YPD 1% DMSO (control) and YPD supplemented with 20 μM of 
different Sortin2‑structural analogs. Afterwards cells were incubated with 
24 μM FM4‑64 for 30 min at 4°C. Then turned to 28°C to be imaged sub‑
sequently by confocal microscopy at different incubation times. Images 
of twenty‑five min incubation are shown. Two images are representative 
of 20 cells. The experiment was performed more than 3 times. Scale bar 
represents 5 μm.
Additional file 6: Figure S5. FM4‑64 reaches the vacuole in Sortin2 
resistant mutants. S. cerevisiae parental line (WT) and Sortin2 resistant 
mutants were grown on YPD (control) and YPD supplemented with 20 μM 
Sortin2. Cells were incubated with 24 μM FM4‑64 for 30 min at 4°C. After 
40 (A) and 60 (B) min at 28°C, cells were imaged by confocal microscopy. 
Images are representative of 20 cells. Scale bar represents 5 μm.
Additional file 7: Table S2. Functional and locational gene product 
categorization of interactome network of genes whose deletion provokes 
resistance to Sortin2 in S. cerevisiae. Category representation of the 
abundance within the Sortin2‑resistance interactome network dataset 
(273 genes) and the S. cerevisiae genome (6,131 genes). p < 0.005 was 
considered as significant.
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